Testing for BRAF V600E and MAP2K1 mutations is especially valuable in challenging cases where ECD may be confused with extracutaneous or disseminated juvenile xanthogranuloma because characteristic genetic aberrations favor the diagnosis of ECD. This evidence concerns the gene MAP2K1 and familial atrioventricular septal defect.